Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes
NCT ID: NCT03392441
Last Updated: 2022-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2017-11-30
2019-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
What are the effects of transient insulin deprivation on circulating exosomes and metabolites in T1DM patients?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Ketosis on Brain Function in Patients With T1DM
NCT04219709
Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)
NCT06144255
"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"
NCT03929419
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
NCT03356457
Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity
NCT01847456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to investigate the effects of insulin deprivation on the human brain, we propose a study involving temporary insulin deprivation in adolescents and adults with type 1 diabetes (T1DM). We will perform brain MRI, phosphorus31 spectroscopy, cognitive testing, circulating blood exosome measurements, and proteomics from muscle biopsy; comparing these measures during insulin treatment and deprivation between diabetic patients and age-, sex-, BMI-matched controls.
Specific aim 1: Determine whether transient insulin deprivation in T1DM adults and adolescents alters brain structure, functions and blood flow as assessed by structural/functional MRI.
Specific aim 2: Determine whether transient insulin deprivation in T1DM adults and adolescents alters cognitive function.
Specific aim 3: Determine whether transient insulin deprivation in T1DM adults and adolescents alters the circulating blood exosome contents and metabolome that can potentially impact brain functions.
Specific aim 4: Determine whether transient insulin deprivation in T1DM adults alters the skeletal muscle proteome homeostasis especially those involved in fission and fusion
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Insulin Deprivation
Insulin Deprivation in Type 1 Diabetic Patients will be performed for a short time period (4-6 hours). Changes to Age, Sex, and Gender matched controls will be compared.
Insulin Deprivation in Type 1 Diabetic Patients
Type 1 Diabetic Patients requiring insulin will have insulin stopped for a short period of time (4-6 hours)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insulin Deprivation in Type 1 Diabetic Patients
Type 1 Diabetic Patients requiring insulin will have insulin stopped for a short period of time (4-6 hours)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-45 years
* Able to provide written consent
* Parents able to provide written consent
* T1DM treated with CSII or MDI (not degludec)
Exclusion Criteria
* BMI z-score \<5th or \>95th percentile
* Celiac disease
* Pregnancy
* Smoking
* Reported history of illicit substance use
* History of active cardiovascular, cerebrovascular, or peripheral vascular disease
* Active renal disease evidenced by estimated GFR \< 50 mL/min/1.73 m2
* History of traumatic brain injury
* Dementia or any other neurologic disease
* Psychiatric disease\\
* Any learning disability
* Hemoglobin A1c \> 8.5%
* Hemoglobin A1c \> 9%
* T2DM, or impaired fasting glucose
14 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
K. Sreekumaran Nair
Consultant Endocrinology and Metabolism
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
K Sreekumaran Nair
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Creo AL, Cortes TM, Jo HJ, Huebner AR, Dasari S, Tillema JM, Lteif AN, Klaus KA, Ruegsegger GN, Kudva YC, Petersen RC, Port JD, Nair KS. Brain functions and cognition on transient insulin deprivation in type 1 diabetes. JCI Insight. 2021 Mar 8;6(5):e144014. doi: 10.1172/jci.insight.144014.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-005244
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.